US Cell Surface Testing Market
Rationale
The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.
This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in the US, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by market segment.
The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.
Competitive Assessments
The report provides strategic assessments of over 15 leading hematology and
flow cytometry market players and start-up companies with innovative
technologies and products, including:
- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Mindray
- Nihon Kohden
- QuidelOrtho
- Roche
- Sekisui Diagnostics
- Siemens Healthineers
- Sysmex and others
II. Worldwide Market and Technology Overview
A. Lymphocyte Subclassification CD4/CD8/CD34
Instrumentation and Reagent Test Kits
* BD
* Beckman Coulter/Danaher
* T Cells Diagnostics
B. CD34
C. Other Cell Markers
D. Instrumentation Review
1. Hematology Analyzers
a. Overview
Electrical Aperture-Impedance Analyzers
Light Scatter Analyzers
b. System Review
Abbott
Beckman Coulter/Danaher
Biocode Hycel
Drew-Scientific
Horiba
Menarini
Nihon Kohden
Siemens
Sysmex
2. Flow Cytometers
a. Introduction
b. System Overview
Becton Dickinson
Beckman Coulter/Danaher
E. Current Market Needs and Future Demand
For Hematology Analyzers
F. Reagents and Controls
G. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
III. U.S. : Forecasts by Test and Market Segment
IV. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized
Testing Markets
1. Four Marketing Approaches
2. Product Complexity Factor
3. Customer Preference Factor
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
V. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. Competitive Assessments
- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Roche
- Siemens Healthineers
- Sysmex
VII. Appendix: Major Universities and Research
Centers Developing Hematology/Flow Cytometry
Technologies and Applications
List Of Tables
U.S., Hospital Laboratories EstimatedCell Surface Marker Test Volume
U.S., Commercial/Private Laboratories Estimated
Cell Surface Marker Test Volume
U.S., Physician Office Laboratories Estimated
Cell Surface Marker Test Volume
U.S., Flow Cytometry Consumables Market
By Major Supplier
U.S., Flow Cytometry Instrument Market
By Major Supplier
U.S., Flow Cytometry Diagnostics Market
By Major Supplier
2024 US Hospital Tumor Marker Testing Market Supplier Shares by Test and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities
2024 US Hospital Tumor Marker Testing Market: Supplier Shares by Test and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging OpportunitiesThis new report from contains 567 pages
USD 3450 View Report2024 US Hospital Microbiology Analyzers and Consumables Tests Supplier Shares and Strategies Volume and Sales Segment Forecasts Technology and Instrumentation Review Emerging Opportunities
2024 US Hospital Microbiology Analyzers and Consumables for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities This new report from contains
USD 3450 View Report2024 US Cell Surface Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts Innovative Technologies Emerging Opportunities
2024US Cell Surface Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Emerging Opportunities RationaleThe use of surface marker identification and classification of cells is spreading beyond
USD 1850 View Report2024 Cell Surface Markers Supplier Shares and Strategies Volume and Sales Segment Forecasts Innovative Technologies Emerging Opportunities
2024Cell Surface Markers: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Emerging OpportunitiesThe use of surface marker identification and classification of cells is spreading beyond
USD 3500 View ReportFill The Form For Sample Request